Skip to main content
ELVElevance Health, Inc.Sell5.0·$417.89+0.41%
ELV · Why this verdict

Why Elevance Health (ELV) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.0/10
ConfidenceMEDIUM
MacroNEUTRAL

Thesis pillars

Three of the four most recent quarters produced earnings beats, with an average surprise of approximately 11% and the most recent quarter delivering a 16.4% positive surprise — the strongest in the trailing year — suggesting consistent above-consensus delivery has been the recent pattern.

Stable
Earnings
Expectation
Continued above-consensus earnings delivery for two more consecutive quarters, with average quarterly EPS surprise remaining above 5%.

CounterThe oldest of the four reported quarters was a miss, indicating the beat pattern is not unbroken; a return to under-delivery is plausible if cost pressures or membership trends deteriorate.

The business scores below the minimum quality threshold required for investment consideration, with notes explicitly flagging no competitive moat and below-average return metrics, leaving the franchise without structural insulation against competitive pressure.

Stable
Quality breakdown
Expectation
Quality score rising above 4.0 and sustained for at least two consecutive quarters, signaling the quality gap has materially narrowed.

CounterQuality metrics can recover if margins improve, but absent a verifiable moat, any improvement may be cyclical rather than structural and could reverse quickly under cost or regulatory pressure.

Price momentum is weak, with falling on-balance volume indicating net selling pressure outweighing accumulation — the momentum dimension sits well below its minimum gate despite the stock trading above the 200-day moving average, signaling that buyers have not stepped in at current levels.

Stable
Momentum breakdown
Expectation
On-balance volume turning positive and momentum recovering above the 4.5 gate for at least two consecutive months, confirming genuine accumulation.

CounterThe stock remains above the 200-day moving average, which historically attracts trend-following buyers; a broader market rally could neutralize the distribution pattern without any company-specific fundamental catalyst.

The reward-to-risk ratio stands at 0.72-to-1 in an unfavorable direction, meaning potential downside materially outweighs the 4.1% remaining headroom to the price target, and the setup fails to meet the minimum asymmetry threshold needed to justify a new position.

Stable
Engine gate (failed)
Expectation
Reward-to-risk ratio improving above 1.5-to-1, driven by a pullback in price that widens the gap to the target.

CounterIf the price declines to create better entry geometry, the quality and momentum deficits flagged elsewhere would still need to resolve for the setup to be genuinely investable on fundamentals.

TrendMatrix Research · core thesis

Engine thesis — one sentence

Elevance Health has delivered three consecutive earnings beats with an average positive surprise of roughly 11%, but the business scores below the minimum quality threshold with no identified competitive moat and a 0.72-to-1 unfavorable reward-to-risk ratio, making the current setup unattractive for new capital with only 4.1% headroom remaining to the price target.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Per-dimension breakdown

Value

6.5/10data confidence 100%
ComponentSub-score
P/E7.2
P/S10.0
EV/EBITDA5.9
Fwd P/E8.2
PEG5.0
Analyst target4.0
  • Forward P/E: 14.3x
  • PEG: 1.52

Quality

3.8/10data confidence 100%
ComponentSub-score
ROE4.0
ROA2.7
Gross margin1.2
Op margin2.1
Net margin1.3
Current ratio5.4
FCF quality6.1
Moat5.0
Piotroski F6.7
  • No competitive moat

Growth

1.6/10data confidence 67%
ComponentSub-score
Rev growth3.1
EPS growth0.0

Momentum

7.3/10data confidence 100%
ComponentSub-score
RSI5.0
MACD10.0
OBV10.0
MA position9.0
Volume2.7
  • Volume accumulation (rising OBV)
  • Above 200-day MA

Sentiment

5.9/10data confidence 100%
ComponentSub-score
LLM sentiment5.0
Analyst rating7.5
Price target5.0

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • Negligible insider selling — $826,625 (0.001% of mkt cap)

Peer rank

5.0/10data confidence 80%
ComponentSub-score
value rank6.0
quality rank6.4
growth rank2.7

Technical

4.5/10data confidence 100%
ComponentSub-score
bollinger1.4
support resistance2.0
52w position9.6
gap5.0

Risk (lower is worse)

6.8/10data confidence 100%
ComponentSub-score
short interest8.4
days to cover6.9
volatility6.0
put call5.8
implied vol4.7
beta8.9
debt equity6.7
  • Concentration risks: 2 MED (10-K Item 1A)

Catalyst

6.6/10data confidence 100%
ComponentSub-score
erm5.0
earnings history6.7
earnings timing5.0
surprise avg8.1
dividend safety7.0
news activity8.0
  • Strong earnings: 3B/1M
  • Earnings in 13 days
  • Dividend: 165.0%

How the verdict was assembled

Engine trigger

Quality below minimum threshold.

Engine technical detail
verdict_path: L1:HARD_BLOCK
Passed (6)
  • MOMENTUM:7.3>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-1.1=NEGATIVE
Warning (1)
  • EARNINGS_PROXIMITY:13d<=14d (soft)
Reward-to-Risk
-1.12
Upside
-9.8%
Downside
8.8%
Sizing output
AVOID

SetupBreakout Golden cross, above all MAs, RSI 61, MACD bullish

EdgeCatalyst-Driven Earnings in 13d with 3/4 beat streak

SuitabilityModerate Balanced profile

Investment implication

The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Momentum at 7.3 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:-1.1=NEGATIVE.

The strongest dimensions are Momentum at 7.3, Risk (lower is worse) at 6.8, and Catalyst at 6.6; the weakest are Growth at 1.6, Quality at 3.8, and Technical at 4.5. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.12 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Recent Earnings Beat Streak

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

  • P2Quality Below Investment Floor

    Trip ifQuality score rises above 4.0 and is sustained for 2 consecutive quarters.

  • P3Momentum Weakness Volume Distribution

    Trip ifOn-balance volume turns positive and momentum score rises above 4.5 for 2 consecutive months.

  • P4Unfavorable Risk Reward Geometry

    Trip ifReward-to-risk ratio improves above 1.5-to-1 at prevailing market price.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks ELV Why this verdict